GLP-1RAs as a support for MCAS For some basics: glucagon-like peptide-1 receptor agonists (abbreviated as GLP-1 medications or as I noted above, GLP-1RAs) are a class of medications that includes semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound, which also work on GIP receptors), as well as in-trials Retatrutide (a triple agonist that works on GLP-1, GIP, and Glucagon receptors)
A new generation of these medications has transformed treatment possibilities for people who have type 2 diabetes (Ozempic, Mounjaro) or who have obesity or are overweight with a related health condition (Wegovy, Zepbound, Foundayo)
The agency identified the lot number (NAR0074) and the serial number (430834149057) of the affected products but warned they could still be available
GLP-1 receptor activated insulin secretion from pancreatic -cells: mechanism and glucose dependence
The medications resist being degraded by DPP-4, which is the enzyme that breaks down naturally produced GLP-1 within a few minutes
I worry about contaminants in supplements